Contamination, Genomics and Licensing - Clinical Research Informer

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Contamination

Genomics

Licensing

Modernizing cell culture processes for the next wave of genomic medicine

Pharmaceutical Technology

FEBRUARY 3, 2023

The field of genomic medicine has reached a true turning point. This is really what has been very challenging for upscaling viral vector production and what leads some companies that have in-licensed projects with a huge amount of viral vector to slightly panic about future production,” she says. Biores Open Access.

Genome

Genome Genomics Medicine Gene Therapy

Advances in cell line development

Drug Discovery World

APRIL 25, 2024

It’s an essential step in determining whether a therapy is effective and can help reduce the cost and time it takes when bringing a drug to market by enabling researchers to submit investigational new drug (IND) or a biologics license application (BLA) to the Food and Drug Administration (FDA).

Development

Development Protein In-Vivo Life Science

Athersys Announces Three Appointments to Board of Directors

The Pharma Data

NOVEMBER 15, 2020

She currently serves as a non-executive director on the board of Genfit, S.A.,

Clinical Trials

Clinical Trials Clinical Trials Production Trials

Modernizing cell culture processes for the next wave of genomic medicine

Advances in cell line development

Athersys Announces Three Appointments to Board of Directors

Stay Connected